Search

everythinglearnresearchcommunity

for

Search:↓

Certain mouse strains develop a skin condition similar to a human hair loss disease due to genetic defects.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

IRS premature desquamation is not unique to CCCA and occurs in various scarring alopecias.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Mast cells may significantly contribute to central centrifugal cicatricial alopecia.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Genetic factors, especially PADI3 gene variants, contribute to CCCA in women of African descent.

A thorough assessment and combined treatment are crucial for managing complex alopecia, especially in patients with skin of color.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Different types of hair loss have unique cellular changes, suggesting new treatment targets.

Targeting cholesterol, fatty acids, fibrosis, and mast cells may help treat CCCA.

Chemical relaxers may cause scarring alopecia in black women.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

The conclusion is that hair loss from CCCA may be genetic and not solely caused by hair grooming practices.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Hair loss in black women needs more research, early intervention, and community education.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Nonscarring alopecia has higher hair density than scarring alopecia, and hair density can help diagnose the type of alopecia.

CCCA is a common scarring hair loss in African descent women, possibly linked to genetics, hair care practices, and health issues like diabetes.

CCCA is a common, progressive hair loss condition that may not always be linked to hair care practices and requires a biopsy for diagnosis.

CCCA affects adolescents too, with genetic and environmental links, requiring careful diagnosis.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

CCCA is a common, scarring hair loss in Black women that needs early detection.